Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart scale spots hidden health wins before weight loss

NCT ID NCT07495696

Knowledge-focused Sponsor: Certmedica International GmbH Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a medical body composition scale (mBCA 555) could pick up early changes in body fat, muscle, and water balance in 41 overweight adults using L112 lipid-binding products. The goal was to find signs of progress that appear before the scale shows weight loss, which could help keep people motivated. The study was exploratory and completed, focusing on measuring many body parameters rather than proving treatment effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

41 people

The number who actually took part.

Started

Apr 2025

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Aschaffenburg and surrounding area

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Declaration of consent * Privacy policy * Adults \> 18 years of age (women and men) * Nutritional profile: High-fat diet / mixed-fat diet * Contraception for participants who could become pregnant Exclusion Criteria: * known allergy to crustaceans or any of the ingredients * underweight (BMI \< 18,5 kg/m²), * pregnant women * breastfeeding mothers * chronic constipation, intestinal obstruction etc. * serious gastrointestinal diseases and condition after operations on the gastrointestinal tract * Long-term use of medication with the exception of contraceptives * Intake of formoline L112, formoline L112 EXTRA, Sterolsan, Liporeform protect, Liposlim nutritabs in the last 4 weeks * Monaten If taken for weight reduction: Weight reduction measure in the last 3 months * Pronounced fluctuations in body weight in the last 3 months * Electrical implants such as pacemakers * Active prostheses * Use of portable electronic medical devices such as infusion pumps or ECG devices * People with cardiac arrhythmia * Acute illnesses * Chronic diseases other than controlled diabetes mellitus * Amputated limbs * Artificial joints * Metal implants with the exception of teeth * Alcohol abuse * Continuous intake of formoline L112 in the last 4 weeks before the start of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overweight

Contacts and locations

Locations

  • Certmedica International GmbH

    Aschaffenburg, Bavaria, 63741, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.